RxDoctor Payments Data

Tabatha Jorgensen

Physician Assistant · Syracuse, NYNPI 1477950400

Payments from drug & device makers

$6,717in general payments, 2019–2025

Across 496 payments — averaging $13.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • UCB, Inc.$837
  • Pfizer$509
  • Lilly USA, LLC$476
  • Teva Pharmaceuticals USA, Inc.$456
  • Catalyst Pharmaceuticals, Inc.$433
  • plus $2K from 17 others

What the payments were for

  • Food & beverage$6,62899%
  • Education$891%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,717 in reported general payments places this provider in the 95th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Medicare billing

Part B allowed, 2024
$78,003
Medicare patients
303
Services billed
5,135

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BriviactBrivaracetam26$70,185
Aimovig AutoinjectorErenumab-Aooe53$42,779
Nurtec OdtRimegepant Sulfate34$40,614
QuliptaAtogepant17$26,369
VimpatLacosamide11$24,930
Ajovy AutoinjectorFremanezumab-Vfrm14$15,315
Emgality PenGalcanezumab-Gnlm20$13,350
UbrelvyUbrogepant13$11,658
Lacosamide108$10,291
NamzaricMemantine Hcl/Donepezil Hcl12$7,130
Carbamazepine ErCarbamazepine39$6,531
Levetiracetam323$6,154
Carbidopa-Levodopa-EntacaponeCarbidopa/Levodopa/Entacapone31$5,044
Carbidopa-LevodopaCarbidopa/Levodopa144$2,242
Mycophenolate Mofetil14$1,985

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
UCB, Inc.Briviact, Vimpat$837$95,11537 claims
AbbVieQulipta, Ubrelvy, Namzaric$1,716$45,15742 claims
PfizerNurtec Odt$509$40,61434 claims
Upsher-smith Laboratories LLCTopiramate$28$1,102124 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Syracuse

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →